Načítá se...

A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma

BACKGROUND: Angiosarcoma is a rare subgroup of soft tissue sarcomas associated with poor prognosis, but paclitaxel has been shown to be active in pretreated metastatic disease. We investigated the efficacy and safety of weekly paclitaxel as first-line chemotherapy in adult patients with metastatic a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Sarcoma Res
Hlavní autoři: Byeon, Seonggyu, Song, Haa-Na, Kim, Hee Kyung, Ham, Jun Soo, Lee, Su Jin, Lee, Jeeyun, Park, Se Hoon
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864900/
https://ncbi.nlm.nih.gov/pubmed/27175275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-016-0048-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!